Understanding and Communicating Measures of Treatment Effect on Survival: Can We Do Better?

Time-to-event end points are the most frequent primary end points in phase III oncology trials, both in the adjuvant and advanced settings. The evaluation of these end points is important to inform clinical practice. However, although different measures can be used to describe the effect of treatmen...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	JNCI : Journal of the National Cancer Institute Jg. 110; H. 3; S. 232
Hauptverfasser:	Saad, Everardo D, Zalcberg, John R, Péron, Julien, Coart, Elisabeth, Burzykowski, Tomasz, Buyse, Marc
Format:	Journal Article
Sprache:	Englisch
Veröffentlicht:	United States 01.03.2018
Schlagworte:	Clinical Trials as Topic - standards Humans Neoplasms - mortality Neoplasms - therapy Outcome Assessment (Health Care) - standards Prognosis Research Design - standards Survival Rate
ISSN:	1460-2105, 1460-2105
Online-Zugang:	Weitere Angaben
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!